The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.20
Bid: 33.00
Ask: 33.40
Change: 0.10 (0.30%)
Spread: 0.40 (1.212%)
Open: 33.10
High: 33.20
Low: 33.10
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New direct investment into Sense Biodetection

30 Oct 2020 07:30

RNS Number : 7421D
Mercia Asset Management PLC
30 October 2020
 

 

Reach

30 October 2020

 Mercia Asset Management PLC

 

("Mercia", the "Company" or the "Group")

 

New direct investment into Sense Biodetection Limited

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£800million of assets under management, is pleased to announce that it has completed a £0.9million new direct investment into Sense Biodetection Limited ("Sense"). Mercia first invested in Sense through its third-party managed EIS funds in 2016.

With operations in both Oxford and Cambridge, Sense is focused on the development of rapid, instrument-free, point-of-care molecular diagnostics testing for a range of bacterial and viral infections. In March 2020, Sense announced an accelerated programme to launch a diagnostic test for COVID-19.

Mercia's direct investment is part of a syndicated funding round with other investors including KDT Sense Holdings LLC, Cambridge Innovation Capital (Jersey) Limited, Earlybird Health GmbH & Co. Beteiligungs KG, and private investors including Abcam founder Jonathan Milner. The total size of the funding round is up to $50million.

Following its investment of £0.9million, Mercia holds a 1.2% fully diluted direct equity stake in Sense, with its third-party managed funds' holding being 9.1%.

Mark Payton, Chief Executive Officer of Mercia, commented:

"We have been tracking Sense through our third-party managed funds and are delighted to now be making our first direct investment as part of this material scale-up funding commitment, alongside such a strong group of investors. Mercia has considerable expertise in Life Sciences and this investment adds another exciting business from the sector into our direct investment portfolio. With the very recent receipt of £1.0million from the sale of Clear Review Limited, this investment clearly demonstrates our ability to 'evergreen' Mercia's balance sheet, by re-investing realisation proceeds into both new and existing portfolio companies."

 

-Ends-

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel, Richard Andrews

 

 

 

N+1 Singer (Joint Broker)

 

Harry Gooden, James Moat

 

+44 (0)20 7496 3000

 

 

FTI Consulting

 

+44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Shiv Talwar

 

mercia@fticonsulting.com

 

 

About Mercia Asset Management PLC:

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£800million of assets under management and, since its IPO in December 2014, has invested over £96million into its direct investment portfolio.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGRBDGUBXDGGG
Date   Source Headline
8th Dec 20239:32 amRNSTransaction in Own Shares
7th Dec 202310:34 amRNSTransaction in Own Shares
6th Dec 202310:17 amRNSTransaction in Own Shares
5th Dec 202312:31 pmRNSTransaction in Own Shares
4th Dec 20238:51 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSDirector/PDMR Dealings
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:58 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSShare buyback programme
28th Nov 20237:00 amRNSInterim Results
23rd Nov 20237:00 amRNSInvestor Presentation
20th Nov 20237:00 amRNSSale of Mercia’s largest direct investment nDreams
18th Oct 20237:00 amRNSFurther direct investment into Netacea
12th Oct 20237:00 amRNSNotice of Interim Results
21st Sep 202311:05 amRNSResult of AGM
21st Sep 20237:00 amRNSAGM Statement
18th Sep 20234:00 pmRNSGrant of SAYE Options
15th Aug 20237:00 amRNSGrant of Options
14th Aug 20231:00 pmRNSTR-1: notification of major holdings
14th Aug 20237:00 amRNSAGM Update: Portfolio Company Presentations
28th Jul 20237:00 amRNSPublication of Annual Report and Notice of AGM
25th Jul 20237:00 amRNSNova Pangaea investment from major airline group
4th Jul 20237:00 amRNSPreliminary Results
28th Jun 20237:00 amRNSInvestor Presentation
13th Jun 20237:00 amRNSMobile and digital gaming portfolio update
7th Jun 20237:00 amRNSWarwick Acoustics secures major contract
11th May 20237:00 amRNSNotice of Results
2nd May 20237:00 amRNSMercia adds c.£80million of managed funds inflows
13th Mar 20237:00 amRNSConfirmation of unrestricted liquidity position
8th Feb 20237:00 amRNSMIP Discovery positive progress update
2nd Feb 202311:29 amRNSTR-1: Notification of major holdings
1st Feb 20234:26 pmRNSTR-1: Notification of major holdings
1st Feb 20237:00 amRNSTotal Voting Rights
26th Jan 20237:00 amRNSDeferred Consideration - Northern VCT Contracts
18th Jan 20237:00 amRNSSale of Intechnica Holdings Limited
6th Jan 20234:48 pmRNSTR-1: Notification of major holdings
20th Dec 20227:00 amRNSnDreams continues its progress with acquisition
6th Dec 20227:00 amRNSAcquisition of Frontier Development Capital
6th Dec 20227:00 amRNSInterim Results
22nd Nov 20227:00 amRNSInvestor Presentation
25th Oct 20227:00 amRNSNotice of Interim Results
24th Oct 20227:00 amRNSVirtual Investor Event
18th Oct 20227:00 amRNSMercia announces two new direct investments
13th Oct 20227:00 amRNSInvestor Event
13th Sep 202212:25 pmRNSResult of AGM
13th Sep 20227:00 amRNSAGM Statement
9th Sep 202211:33 amRNSGrant of SAYE Options
29th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
26th Jul 20227:00 amRNSGrant of Options
7th Jul 202211:51 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.